Article
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer
9 Nov 2023
Abstract excerpt
PURPOSE: The gastric adenocarcinoma (GC) represents the third cause of cancer-related mortality worldwide, and available therapeutic options remain sub-optimal. The Fibroblast growth factor receptors (FGFRs) are oncogenic transmembrane tyrosine kinase receptors. FGFR inhibitors have been approved for the treatment of various cancers and a STAT3-dependent regulation of FGFR4 has been documented in the H.pylori...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
